30.01.2015 • News • Dede Willams • Fine Chemicals & Specialty Chemicals • Lanxess

Lanxess Says 2014 Earnings Exceed Expectations

German specialty chemicals producer Lanxess expects to show higher than anticipated EBITDA pre-exceptionals for the fourth quarter and full year 2014, when it presents its annual results on March 19, CEO Matthias Zachert said.

For the fourth quarter, Lanxess expects to report about EBITDA pre exceptionals of about €154 million, thanks to stronger than originally expected demand in December.

The pre-exceptionals earning figure for the full year is forecast to come in at around €808 million, up from the €735 million reported for 2013.

"In autumn, Zachert said, "we were witnessing restrained orders due to customer destocking in the rubber business in light of falling oil prices. "Surprisingly, this development was considerably less strong in December."

The CEO said Lanxess profited additionally from lower raw material costs in the Advanced Intermediates segment, while earnings in the Performance Chemicals segment were flat.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Top-Feature